Vanguard Group Inc Viking Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,164,257 shares of VKTX stock, worth $325 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,164,257

Previous 10,172,441 0.08%

Holding current value

$325 Million

Previous $409 Million 40.03%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$24.15 - $42.89 $197,643 - $351,011	-8,184 Reduced 0.08%	10,164,257 $245 Million
Q4 2024 Feb 11, 2025	BUY	$38.28 - $78.03 $184,777 - $376,650	4,827 Added 0.05%	10,172,441 $409 Million
Q3 2024 Nov 13, 2024	BUY	$49.84 - $70.47 $3.5 Million - $4.95 Million	70,277 Added 0.7%	10,167,614 $644 Million
Q2 2024 Aug 13, 2024	BUY	$47.39 - $80.2 $110 Million - $185 Million	2,311,613 Added 29.69%	10,097,337 $535 Million
Q1 2024 May 10, 2024	BUY	$17.4 - $94.5 $41.8 Million - $227 Million	2,403,820 Added 44.66%	7,785,724 $638 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $901,380 - $1.92 Million	97,552 Added 1.85%	5,381,904 $100 Million
Q3 2023 Nov 14, 2023	BUY	$10.92 - $16.0 $1.88 Million - $2.75 Million	171,995 Added 3.36%	5,284,352 $58.5 Million
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $15.6 Million - $26.1 Million	1,053,718 Added 25.96%	5,112,357 $82.9 Million
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $5.92 Million - $12.7 Million	732,968 Added 22.04%	4,058,639 $67.6 Million
Q4 2022 Feb 10, 2023	SELL	$2.72 - $9.4 $14,736 - $50,929	-5,418 Reduced 0.16%	3,325,671 $31.3 Million
Q2 2022 Aug 12, 2022	SELL	$2.11 - $3.15 $737,299 - $1.1 Million	-349,431 Reduced 9.49%	3,331,089 $9.63 Million
Q1 2022 May 13, 2022	BUY	$3.0 - $4.88 $889,059 - $1.45 Million	296,353 Added 8.76%	3,680,520 $11 Million
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $88,389 - $129,124	19,215 Added 0.57%	3,384,167 $15.6 Million
Q3 2021 Nov 12, 2021	BUY	$5.58 - $7.04 $469,512 - $592,359	84,142 Added 2.56%	3,364,952 $21.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.19 - $6.73 $17 Million - $22.1 Million	3,280,810 New	3,280,810 $19.7 Million

Others Institutions Holding VKTX

# of Institutions

447

Shares Held

65.4M

Call Options Held

8.28M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.45B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Viking Therapeutics, Inc. Transaction History